Logo image of PCOR

PROCORE TECHNOLOGIES INC (PCOR) Stock Fundamental Analysis

NYSE:PCOR - New York Stock Exchange, Inc. - US74275K1088 - Common Stock - Currency: USD

82.895  -3.59 (-4.15%)

Fundamental Rating

4

Taking everything into account, PCOR scores 4 out of 10 in our fundamental rating. PCOR was compared to 284 industry peers in the Software industry. While PCOR seems to be doing ok healthwise, there are quite some concerns on its profitability. PCOR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PCOR had negative earnings in the past year.
PCOR had a positive operating cash flow in the past year.
PCOR had negative earnings in each of the past 5 years.
PCOR had a positive operating cash flow in each of the past 5 years.
PCOR Yearly Net Income VS EBIT VS OCF VS FCFPCOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.04%, PCOR is in line with its industry, outperforming 47.10% of the companies in the same industry.
PCOR's Return On Equity of -8.22% is in line compared to the rest of the industry. PCOR outperforms 50.72% of its industry peers.
Industry RankSector Rank
ROA -5.04%
ROE -8.22%
ROIC N/A
ROA(3y)-10.51%
ROA(5y)-11.86%
ROE(3y)-16.78%
ROE(5y)-18.88%
ROIC(3y)N/A
ROIC(5y)N/A
PCOR Yearly ROA, ROE, ROICPCOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

PCOR's Gross Margin of 82.17% is amongst the best of the industry. PCOR outperforms 86.96% of its industry peers.
In the last couple of years the Gross Margin of PCOR has remained more or less at the same level.
PCOR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y0.13%
PCOR Yearly Profit, Operating, Gross MarginsPCOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

5

2. Health

2.1 Basic Checks

PCOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PCOR has more shares outstanding
The number of shares outstanding for PCOR has been increased compared to 5 years ago.
Compared to 1 year ago, PCOR has an improved debt to assets ratio.
PCOR Yearly Shares OutstandingPCOR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
PCOR Yearly Total Debt VS Total AssetsPCOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

PCOR has an Altman-Z score of 9.18. This indicates that PCOR is financially healthy and has little risk of bankruptcy at the moment.
PCOR has a better Altman-Z score (9.18) than 78.62% of its industry peers.
PCOR has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
The Debt to FCF ratio of PCOR (0.33) is better than 77.17% of its industry peers.
PCOR has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
PCOR has a Debt to Equity ratio (0.03) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.33
Altman-Z 9.18
ROIC/WACCN/A
WACC14.1%
PCOR Yearly LT Debt VS Equity VS FCFPCOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

PCOR has a Current Ratio of 1.51. This is a normal value and indicates that PCOR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.51, PCOR is in line with its industry, outperforming 46.38% of the companies in the same industry.
PCOR has a Quick Ratio of 1.51. This is a normal value and indicates that PCOR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.51, PCOR is in line with its industry, outperforming 46.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
PCOR Yearly Current Assets VS Current LiabilitesPCOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.51% over the past year.
The Revenue has grown by 21.24% in the past year. This is a very strong growth!
The Revenue has been growing by 31.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)46.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.8%
Revenue 1Y (TTM)21.24%
Revenue growth 3Y30.79%
Revenue growth 5Y31.83%
Sales Q2Q%16.15%

3.2 Future

Based on estimates for the next years, PCOR will show a very strong growth in Earnings Per Share. The EPS will grow by 25.51% on average per year.
PCOR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.55% yearly.
EPS Next Y17.61%
EPS Next 2Y23.99%
EPS Next 3Y25.51%
EPS Next 5YN/A
Revenue Next Year12.5%
Revenue Next 2Y13.55%
Revenue Next 3Y14.78%
Revenue Next 5Y17.55%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PCOR Yearly Revenue VS EstimatesPCOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PCOR Yearly EPS VS EstimatesPCOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 -0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PCOR. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 66.49, the valuation of PCOR can be described as expensive.
PCOR's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.75. PCOR is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 66.49
PCOR Price Earnings VS Forward Price EarningsPCOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

PCOR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 99.61
EV/EBITDA N/A
PCOR Per share dataPCOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PCOR's earnings are expected to grow with 25.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.99%
EPS Next 3Y25.51%

0

5. Dividend

5.1 Amount

PCOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PROCORE TECHNOLOGIES INC

NYSE:PCOR (2/20/2025, 2:27:08 PM)

82.895

-3.59 (-4.15%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners86.36%
Inst Owner Change1.93%
Ins Owners7.63%
Ins Owner Change-11.47%
Market Cap12.32B
Analysts78.57
Price Target94.24 (13.69%)
Short Float %6.52%
Short Ratio5.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.16%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)0.88%
Revenue beat(4)3
Avg Revenue beat(4)0.49%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)1.28%
Revenue beat(8)7
Avg Revenue beat(8)1.81%
Revenue beat(12)11
Avg Revenue beat(12)2.61%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.33%
PT rev (3m)29.79%
EPS NQ rev (1m)1.79%
EPS NQ rev (3m)3.39%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.49%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 66.49
P/S 10.7
P/FCF 99.61
P/OCF 62.82
P/B 9.57
P/tB 24.38
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)1.25
Fwd EY1.5%
FCF(TTM)0.83
FCFY1%
OCF(TTM)1.32
OCFY1.59%
SpS7.75
BVpS8.67
TBVpS3.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.04%
ROE -8.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.17%
FCFM 10.74%
ROA(3y)-10.51%
ROA(5y)-11.86%
ROE(3y)-16.78%
ROE(5y)-18.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y0.13%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.33
Debt/EBITDA N/A
Cap/Depr 80.74%
Cap/Sales 6.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 9.18
F-Score7
WACC14.1%
ROIC/WACCN/A
Cap/Depr(3y)77.64%
Cap/Depr(5y)76.37%
Cap/Sales(3y)6.24%
Cap/Sales(5y)5.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.8%
EPS Next Y17.61%
EPS Next 2Y23.99%
EPS Next 3Y25.51%
EPS Next 5YN/A
Revenue 1Y (TTM)21.24%
Revenue growth 3Y30.79%
Revenue growth 5Y31.83%
Sales Q2Q%16.15%
Revenue Next Year12.5%
Revenue Next 2Y13.55%
Revenue Next 3Y14.78%
Revenue Next 5Y17.55%
EBIT growth 1Y37.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y215.74%
FCF growth 3Y138.66%
FCF growth 5YN/A
OCF growth 1Y113.2%
OCF growth 3Y74.8%
OCF growth 5YN/A